EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Dynavox Group (DYVOX) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Dynavox Group SEK 32.16, price SEK 76.85, upside -58.2%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · SE · ISIN SE0017105620

DG Some data Sep 24, 2026

Dynavox Group

DYVOX · ST

Weakest SetupStrongly overvalued and low quality.

!Fair value kr 32.16 · Strongly overvalued (−58%)
!Quality 49/100
!Expensive Growth (revenue 5y +22.5 %/yr)
!Thin margins · 7.3% net margin (TTM)
!Moderate debt · negative free cash flow
·0.65% dividend yield
!Trails peers (3/13)
!Moderate moat 60/100
!Insider activity 40/100
!Evidence only medium, so the estimate is less certain
!Weak on future: 6 out of 100
!Weak on dividend: 13 out of 100
Watch Dynavox Group for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 130.52 kr 17.61 Fair Value kr 32.16 Dec 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

57‑month range kr 17.61 – kr 130.52 · fair‑value band kr 21.97 – kr 42.34 · the kr 76.85 price screens above the kr 32.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Dynavox in your weekly email

Every Wednesday you see whether Dynavox is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities.

Show more

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own. Its communication solutions include language, software, hardware, funding, support, and training. The company operates in Sweden, Norway, Denmark, Belgium, the United States, Germany, France, China, the United Kingdom, Ireland, Australia, and New Zealand. The company was formerly known as Tobii Dynavox AB (publ) and changed its name to Dynavox Group AB (publ) in July 2024. Dynavox Group AB (publ) was incorporated in 2012 and is headquartered in Stockholm, Sweden.

Stock analysis

Dynavox Group (DYVOX) currently trades at kr 76.85, while our model-based Fair Value estimate is kr 32.16, implying the stock looks roughly 138.9% overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of kr 49.83 per share, and 0 of the 15 models we run sit above the kr 76.85 price.

Bear case: the Asset-Based group reads lowest at kr 3.81, and 15 of the 15 models stay below the price. Evidence for this calculation is medium.

Scenario range: kr 21.97 (bear) to kr 42.34 (bull), the price of kr 76.85 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Dynavox Group reported revenue of 2.5B SEK in FY2025 versus 871M SEK in FY2021, a compound +29.7%/yr. Reported net income was 166M SEK in FY2025, compounding +53.6%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.

Key figures

Market cap 8.2B SEK (≈ $827M) · P/E ratio 45.5 · P/S ratio 3.05 · EPS (TTM) kr 1.69 · Dividend yield 0.7% · Net margin 6.7% · Return on equity 32.5% · Return on assets (EBIT) 8.4%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).

What moves the price

The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.

The share trades about 34% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at −58%, DYVOX screens richer than that median.

Fair Value models

Bear kr 21.97 Fair Value kr 32.16 Bull kr 42.34
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (kr 0.8705 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV kr 10.05 kr 12.23 kr 14.05 74
Owner Earnings kr 20.84 kr 49.60 kr 102.97 71
ROIC Compounder kr 13.03 kr 20.88 kr 25.65 71
All 15 models by family
DCF Models
Owner Earnings kr 20.84 kr 49.60 kr 102.97 71
Earnings-Based
Graham-Dodd kr 10.62 kr 74.09 kr 103.97 63
Lynch FV kr 26.42 kr 37.74 kr 49.07 61
PEG = 1.0 kr 26.42 kr 37.74 kr 49.07 57
EPV kr 10.05 kr 12.23 kr 14.05 74
Multiples
P/E Multiple kr 25.78 kr 34.37 kr 42.96 63
P/S Multiple kr 19.92 kr 26.56 kr 33.20 58
P/B Multiple kr 19.17 kr 25.56 kr 31.95 55
EV/EBIT kr 24.56 kr 34.75 kr 44.93 65
EV/EBITDA kr 41.72 kr 57.61 kr 73.51 67
EV/Revenue kr 15.82 kr 25.16 kr 34.51 53
Asset-Based
NCAV (Graham) kr 2.84 kr 3.81 kr 5.68 54
Economic Profit
Residual Income kr 9.09 kr 12.41 kr 64.59 58
ROIC Compounder kr 13.03 kr 20.88 kr 25.65 71
Growth Earnings
Growth-Adj P/E kr 34.88 kr 49.83 kr 64.78 67

Open the full fair value analysis →

Notify me when DYVOX reaches fair value

Put DYVOX on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 49/100

Of which business quality 49 · Market factors (momentum, volatility) 39

Profitability 70
Margins and returns on capital today
Quality Growth 55
Are margins and returns improving?
Cashflow 25
Earnings quality: real cash, not paper profit
Fin. Strength 44
Balance sheet, leverage, solvency risk
Investment 22
Disciplined investing over empire-building
Low Volatility 57
Calm price path (market factor)
Momentum 41
Price trend over the last 3–12 months (market factor)
52W Momentum 16
Distance to the 52-week high (market factor)
Net Issuance 79
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+25.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.5%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.1%
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+41.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+40.5%
Dividend (yield on the price)0.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.14% → 10%
2025 sits 59% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

DYVOX screens 139% overvalued. Compare with Intuitive Surgical, Inc →

Compare Dynavox Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 203 stocks

Beats the industry median on 3/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 49 · Below median
Fair Value upside −58% · Bottom 25%
Profitability
Return on equity (TTM) 32% · Top 25%
Return on assets 9% · Top 25%
Net margin (TTM) 7% · Above median
Operating margin (TTM) 10% · Below median
Growth and dividend
Revenue growth 1% · Below median
Dividend yield (TTM) 0.7% · Bottom 25%
Balance sheet
Debt / equity 1.38× · Highest 25%

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/E (TTM) 45.5× · Pricier than median
P/B 13.59× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM) 3.31× · Pricier than median
EV/EBITDA 22.7× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 15
FUTURE (revenue growth)6 · sector 31
PAST (return on equity)100 · sector 25
HEALTH (low debt)31 · sector 96
DIVIDEND (yield)13 · sector 33

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $402.09 $353.38 −12%
EssilorLuxottica Société anonyme EL €144.50 €158.95 +10%
Medline Inc MDLN $34.43 $30.15 −12%
Becton, Dickinson and Company BDX $183.00 $103.53 −43%
Alcon Inc ALC $65.59 $39.78 −39%
ResMed Inc RMD A$31.61 A$34.77 +10%
West Pharmaceutical Services, Inc WST $371.09 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €206.40 €54.82 −73%
Straumann Holding STMN CHF 97.86 CHF 45.50 −54%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Dynavox Group · Fair Value
kr 32.16 −139%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Dynavox Group Fair Value". https://www.fairvalue-calculator.com/stock/DYVOX

Frequently asked questions

Is Dynavox Group (DYVOX) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of kr 32.16 versus a price of kr 76.85, about −58% upside (overvalued).
What is the fair value of DYVOX?
Our model-based fair value for Dynavox Group is kr 32.16 (as of Sep 24, 2026), built from audited fundamentals. The current price: kr 76.85.
What is the quality score of DYVOX?
Dynavox Group has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Dynavox Group (DYVOX)?
Our model-based price target is the fair value of kr 32.16 (as of Sep 24, 2026) from 15 valuation models. Cautious scenario kr 21.97, optimistic scenario kr 42.34. It is a calculation from audited fundamentals, not an analyst target.
What is the Dynavox Group stock forecast for 2026?
Our models put fair value at kr 32.16, about −58% upside versus a price of kr 76.85 (overvalued). Cautious scenario kr 21.97, optimistic scenario kr 42.34. The calculation is refreshed regularly with new filings.
What is the revenue of Dynavox Group (DYVOX)?
Dynavox Group reported trailing-twelve-month revenue of about 2.5B SEK (latest available figure, as of Sep 24, 2026).
Does Dynavox Group pay a dividend?
Dynavox Group currently shows a dividend yield of about 0.65% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Dynavox Group (DYVOX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Dynavox Group it is kr 32.16 per share (as of Sep 24, 2026), against a price of kr 76.85. It is the blended result of 15 valuation models (cash flow, earnings, asset, dividend).
Is Dynavox Group stock overvalued or undervalued in 2026?
As of Sep 24, 2026, DYVOX trades above its calculated fair value: price kr 76.85, fair value kr 32.16, a gap of about −58% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DYVOX?
No. The price is what the market pays today (kr 76.85); the fair value is what the company's own numbers justify (kr 32.16). For Dynavox Group the two are kr 44.69 per share apart. That gap is exactly why we show both numbers side by side.
How much is Dynavox Group worth?
The market values Dynavox Group at about 8.2B SEK (market capitalisation, as of Sep 24, 2026). Per share that is kr 76.85; our models calculate a fair value of kr 32.16 per share.
What do the bullish and bearish scenarios say about DYVOX?
Our models span a range for Dynavox Group: cautious scenario kr 21.97, base kr 32.16, optimistic kr 42.34 per share (as of Sep 24, 2026, price kr 76.85). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of DYVOX?
Dynavox Group trades at a price-to-earnings ratio of 45.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 32.16 is built from several models across several years. Other multiples: P/B 13.6, P/S 3.3, EV/EBITDA 22.7.
How solid is the balance sheet of Dynavox Group (DYVOX)?
Balance-sheet figures for Dynavox Group (as of Sep 24, 2026): return on equity 32.5%, debt of 1.38 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is DYVOX from its 52-week high?
Dynavox Group trades at kr 76.85, about 34% below its 52-week high of kr 116.01 and 32% above the low of kr 58.10 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of kr 32.16 is for.
Which stocks are comparable to Dynavox Group?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Dynavox Group stock attractive at the current price?
The data as of Sep 24, 2026: price kr 76.85, calculated fair value kr 32.16 (−58%), Quality Score 49/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DYVOX calculated?
We run Dynavox Group through 15 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 32.16, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Dynavox Group itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Dynavox Group (DYVOX)?
The closing price on Sep 23, 2026 was kr 76.85. Our model-based fair value is kr 32.16, about −58% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Dynavox Group right now?
The price sits above even our optimistic bull case (kr 42.34). The favourable scenario is already priced in. Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (kr 21.97 to kr 42.34) leaves room in how you read the outcome.

Key figures of Dynavox Group

How large is the market capitalisation of Dynavox Group (DYVOX)?
The market capitalisation of Dynavox Group is 8.2B SEK (≈ $827M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Dynavox Group (DYVOX)?
The price-to-sales ratio of Dynavox Group is 3.05 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Dynavox Group (DYVOX)?
Earnings per share at Dynavox Group are kr 1.69 (price ÷ EPS = P/E 45.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Dynavox Group (DYVOX)?
The dividend yield of Dynavox Group is 0.7% (payout 29.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Dynavox Group (DYVOX)?
The net margin of Dynavox Group is 6.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Dynavox Group (DYVOX)?
The return on equity (ROE) of Dynavox Group is 32.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Dynavox Group (DYVOX)?
On an EBIT basis the return on assets of Dynavox Group is 8.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Dynavox Group (DYVOX)?
The operating margin of Dynavox Group is 9.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Dynavox Group (DYVOX)?
Revenue at Dynavox Group is growing +1.2% versus a year earlier (3y avg +26.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Dynavox Group (DYVOX)?
Earnings per share at Dynavox Group are growing +59.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Dynavox Group (DYVOX) generate?
The free cash flow of Dynavox Group is −8.3M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Dynavox Group (DYVOX) carry?
The net debt of Dynavox Group is 909M SEK (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Dynavox Group in the live analysis

One click puts Dynavox Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.